FDA Issues Warning Letter to Sprout Pharmaceuticals
June 11, 2025
June 11, 2025
WASHINGTON, June 11 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Sprout Pharmaceuticals Inc.:
* * *
To: Cindy Eckert, Chief Executive Officer, Sprout Pharmaceuticals, Inc., 4350 Lassiter at North Hills Ave., #260, Raleigh, NC 27609, United States
Dear Cindy Eckert:
The Office of Prescription Drug Promotion (OPDP) of the U.S. Food and Drug Administration (FDA) has reviewe . . .
* * *
To: Cindy Eckert, Chief Executive Officer, Sprout Pharmaceuticals, Inc., 4350 Lassiter at North Hills Ave., #260, Raleigh, NC 27609, United States
Dear Cindy Eckert:
The Office of Prescription Drug Promotion (OPDP) of the U.S. Food and Drug Administration (FDA) has reviewe . . .